Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | VG2025 |
Trade Name | |
Synonyms | VG-2025|VG 2025 |
Drug Descriptions |
VG2025 is an oncolytic herpes simplex virus-1 (HSV-1) engineered to express IL-12 and IL-15/IL-15Ralpha, which potentially induces an antitumor immune response (PMID: 36938544). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187035 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
VG2025 | VG2025 | 0 | 2 |